Healthcare Review: Fluidigm Corporation, Medical Action, Senomyx, SIGA Technologies, CareFusion Corporation Print E-mail
By Staff and Wire Reports   
Friday, 02 August 2013 13:55
U.S. stocks were little changed and bonds rallied Friday after the July jobs report fell short of forecasts. The Labor Department reported the economy created 162,000 jobs in July and the unemployment rate fell to 7.4%. Economists polled by MarketWatch had forecast growth of 180,000 jobs and some analysts had grown even more optimistic, calling for a gain of above 220,000.

Fluidigm Corporation (NASDAQ:FLDM) shares gained 10.85% to $19.72 in the morning hour. The company on August 1 announced its financial results for the second quarter ended June 30, 2013. Total revenue for the second quarter of 2013 was $17.5 million, an increase of 35% from $12.9 million in the second quarter of 2012. Net loss for the second quarter of 2013 was $4.0 million, compared to a net loss of $4.6 million in the second quarter of 2012. Non-GAAP net loss for the second quarter of 2013 was $1.7 million, compared with a $2.8 million non-GAAP net loss for the second quarter of 2012.

Medical Action Industries (NASDAQ:MDCI) stock increased 8.01% to $6.74. The company on August 1 reported financial results for the first quarter ended June 30, 2013. Net sales for the first quarter of fiscal year 2014 were $107.2 million, down $5.0 million or 4.5% from net sales of $112.2 million for the first quarter of fiscal year 2013. Net income for the first quarter of fiscal year 2014 was $0.3 million or $0.02 per diluted share, compared to a reported net loss of $0.1 million or $0.01 per diluted share for the same period of fiscal year 2013.

Senomyx Inc. (NASDAQ:SNMX) stock jumped 10.83% to $3.07. The company on August 1 reported financial results for the second quarter 2013. The Company ended the second quarter with $37.5 million in cash and highly liquid investments. Total revenues were $7.7 million for the quarter ended June 30, 2013, an increase from $6.9 million for the quarter ended June 30, 2012. Total revenues for the six months ended June 30, 2013 were $15.1 million compared to $15.2 million for the six months ended June 30, 2012. The net loss for the quarter ended June 30, 2013 was $0.06 per share, compared to $0.08 per share for the quarter ended June 30, 2012. The net loss for the six months ended June 30, 2013 was $0.13 per share compared to $0.12 per share for the six months ended June 30, 2012.

SIGA Technologies, Inc. (NASDAQ:SIGA) stock gained 8.16% to $3.52. The company announced that management will host a conference call and simultaneous webcast to provide a quarterly business update at 4:30 P.M. ET on Monday, August 5, 2013.

Additionally, the company on August 1 announced that it has selected a lead candidate for its dengue fever antiviral program. "Identifying a lead candidate is an early but crucial step in a long journey to develop a dengue fever drug," said Dr. Dennis E. Hruby, SIGA's Chief Scientific Officer. "Our new, orally bioavailable lead candidate compound appears to have a novel mechanism of action against all four serotypes of dengue virus in vitro at the nanomolar level, and to demonstrate efficacy in mouse models. Having selected a lead preclinical candidate compound, we intend to start scal-eup and formulation work as we pursue Investigational New Drug (IND)-enabling studies."

CareFusion Corporation (NYSE:CFN) shares declined 8.93% to $35.47. The company announced plans to release fourth quarter and fiscal 2013 results on Thursday, Aug. 8, following the close of trading on the New York Stock Exchange. The company will host a conference call on Aug. 8 at 2 p.m. PDT (5 p.m. EDT) to discuss the results for the quarter and year, ended on June 30, 2013, as well as provide guidance for fiscal 2014.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter